Pravastatin Sodium USP, tablets, 40 mg, 90-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-487-09
Published November 29, 2017 · Recall initiated: November 17, 2017
Summary
FDA records drug Class II recall D-0092-2018, published November 29, 2017 and initiated November 17, 2017. Recalling firm: Lupin Limited; Status: Terminated; Reported quantity: N/A; Lot: Lot # G702459, Exp 2/20. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of foreign tablets/capsules: This product lot is being recalled due to a pharmacy complaint where one Duloxetine Delayed Release Capsule, 30mg was found in a Pravastatin Sodium Tablets USP, 40mg bottle.
What to do
Voluntary: Firm initiated · Letter
Get an email if PRAVASTATIN SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PRAVASTATIN SODIUM
- Manufacturer
- Lupin Limited
- Distributor
- Product was distributed throughout the United States, including Puerto Rico.
- UPC
- 0368180487098
- Lot
- Lot # G702459, Exp 2/20
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAPravastatin Sodium Tablets, USP, 20mg, a).90-count bottle, Rx Only, Mfd for: Northstar Rx LLC, Memphis, TNApril 16, 2025
- FDAPravastatin Sodium Tablets, 20mg, a).500-count bottle (NDC# 68462-196-05), b). 90-count bottle (NDC#April 16, 2025
- FDAPravastatin Sodium Tablets, USP, 80mg, a).90-count bottle (16714-570-01), b). 500-count bottle (NDCApril 16, 2025
- FDAPravastatin Sodium Tablets 80mg, 90-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,April 16, 2025
- FDAParoxetine Tablets, USP, 30mg, 100 tablets (10 x 10) , Rx Only, Distributed by: American Health Packaging,November 29, 2017
- FDADexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Vials (NDC 0641-6145-01), packaged in 25 x 1 mLNovember 29, 2017
Questions about this recall
Was Pravastatin Sodium USP, tablets, 40 mg, 90-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-487-09 recalled?
Yes. FDA published recall D-0092-2018 on November 29, 2017. Reported hazard: Presence of foreign tablets/capsules: This product lot is being recalled due to a pharmacy complaint where one Duloxetine Delayed Release Capsule, 30mg was found in a Pravastatin Sodium Tablets USP, 40mg bottle.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PRAVASTATIN SODIUM. UPC: 0368180487098.